Generation and analysis of anti-ganglioside antibodies for the immunotherapeutic treatment of high-risk neuroblastoma
- Weitere Titel
-
Generation und Analyse von Anti-Gangliosid Antikörpern für die immuntherapeutische Behandlung beim Hochrisiko-Neuroblastom
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Hamburg, Universität Hamburg, Dissertation, 2023
- Schlagwort
-
Immuntherapie
Antikörper
Krebs
Therapie
Kind
Ganglioside
Neuroblastom
Antikörper
Immuntherapie
Immunologie
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Hamburg
- (wer)
-
Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky
- (wann)
-
2023
- Urheber
-
Rekowski, Laura
- Beteiligte Personen und Organisationen
-
Müller, Ingo
- URN
-
urn:nbn:de:gbv:18-ediss-113867
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rekowski, Laura
- Müller, Ingo
- Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky
Entstanden
- 2023
Ähnliche Objekte (12)
Anti-ganglioside antibodies and celiac disease
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Ganglioside als Virusrezeptoren
Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
Regenerationsförderung traumatischer Hirnläsionen durch Ganglioside
Functional validation of novel target structures for treatment of high-risk neuroblastoma
GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells
Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity
Anti-ganglioside antibodies and celiac disease
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Ganglioside als Virusrezeptoren
Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
Regenerationsförderung traumatischer Hirnläsionen durch Ganglioside
Functional validation of novel target structures for treatment of high-risk neuroblastoma
GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells
Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity
Anti-ganglioside antibodies and celiac disease
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Ganglioside als Virusrezeptoren
Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
Regenerationsförderung traumatischer Hirnläsionen durch Ganglioside
Functional validation of novel target structures for treatment of high-risk neuroblastoma
GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells